Taiwan is intensifying efforts to combat cardiovascular disease, the nation’s second leading cause of death, through initiatives like the NHIA’s 888 Plan and telehealth innovations from iXensor. A focus on preventive care, early intervention, and expanded access to advanced treatments aims to improve outcomes and reduce healthcare burdens.

In September, Taiwan’s National Health Insurance Administration expanded coverage to 46 da Vinci robotic-assisted surgeries, benefiting 8,400 patients annually. Patients now only pay material copayments, adding NT$285 million (US$8.75 million) to the NHI budget. This change boosts healthcare efficiency and improves patient outcomes, with fewer complications and faster recoveries, making robotic-assisted surgery a cost-effective long-term solution despite initial costs.

Becton, Dickinson and Co. (BD) has evolved from a syringe manufacturer into a leading MedTech company, driving digital transformation in healthcare with solutions like automated pharmacy systems that improve efficiency and patient outcomes. In Taiwan, BD’s innovations align with the government’s “Healthy Taiwan” initiative, as the country aims to establish itself as a MedTech hub. Despite Taiwan’s strengths in electronics and healthcare, challenges such as improving software and aligning regulatory standards with global norms remain. As AI becomes integral to healthcare, addressing these issues will be crucial for Taiwan’s MedTech competitiveness.

In recent years, Taiwan has transformed its energy landscape, culminating in the elevation of the Bureau of Energy to the Energy Administration in 2023. A discussion with Deputy Director General Lee Chun-li highlighted the nation’s commitment to achieving net-zero carbon emissions, with a focus on diversifying renewable energy sources and enhancing energy security amid global geopolitical tensions.

In Taiwan, the critical need for adult vaccinations is growing, yet many adults are not up-to-date due to financial barriers and lack of awareness. Vaccines like HPV and flu are often not covered by public health insurance for adults, leading to lower vaccination rates. Improving public education, making vaccines more accessible, and learning from successful vaccination strategies can enhance adult immunization and public health.

Amgen Taiwan’s General Manager Daniel Villegas began his career in the fast-moving consumer goods space before transitioning into biopharmaceuticals. His professional journey has spanned four continents and covered various therapeutic areas, from rare diseases to immunology. A California native, Villegas earned his BA from San Diego State University and MBA from Michigan State University. In…